We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Boston Scientific and Biophan in MRI Collaboration

By HospiMedica staff writers
Posted on 21 Nov 2003
Print article
An agreement to make medical devices more compatible with magnetic resonance imaging (MRI) has been announced by Boston Scientific Corp. (Boston, MA, USA) and Biophan Technologies, Inc. (Rochester, NY, USA).

The joint development program will seek to resolve problems caused by the interference of metal objects, including medical devices, with MRI technology. Since interference can obscure images of tissue, bone, and metal in areas near metal objects and pose safety problems, some medical devices are not permitted near MRI diagnostic tools. Biophan develops and markets technology to enable biomedical devices to be safe and compatible with MRI and other equipment using magnetic fields and radio waves. The company has also developed a coating technology that can reduce image interference caused by metal objects. Boston Scientific develops and markets medical devices used in a broad range of interventional specialties.

"We are pleased to be working with Boston Scientific on the demonstration of our technology on specific products that today are limited for use with MRI, " said Michael Weiner, CEO of BioPhan. "Biophan's goal is to make medical devices both safe and compatible with MR imaging.”





Related Links:
Boston Scientific
BioPhan
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Tablet Cart
Tryten P1
New
4K SURGICAL MONITOR
TM343

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.